what is b cell lymphoma | What is the T-cell Cutaneous Lymphoma...

What is the T-cell Cutaneous Lymphoma...


What is the T-cell Cutaneous Lymphoma...
Skin cancer has long been something closely associated with exposure to the Sun. Despite the frequency of certain cancers are caused by a history of periods of contact with the extended sunlight, there are a few skin cancers that are not related to this at all. Some of them can be fatal while others are considered completely conditions not life-threatening. Cancer is a cutaneous T-cell lymphoma. Although treatable, there is no cure for this condition, and many patients will live with this cancer for the rest of their lives.

The T lymphocytes (or T cells) are a type of white blood cell of the lymphatic system that protects the body against infection. Play a major role in the immune system, T cells find and eliminate infections, bacteria, and viruses. Produced in the bone marrow, these cells grow and develop in the thymus (which they get their name): a lymphoid organ just below the sternum, and close to the heart. T cells carry unique receivers that allow them to react to, seek, and attacks virtually any antigen present in the body. In other words, of course, unless they are infected themselves.

Cutaneous T-cell lymphoma is a non Hodgkin Lymphoma type that directly attacks the t-cells of the human body. One of the many variants of T-cell lymphoma, the variety skin (CTCL) begins in cells present in the skin, turning malignant cells. Cancer is characterized by an abnormal growth of infected lymphocytes. These malignant cells can grow and move throughout the body, in the skin, lymph nodes, organs, blood and bone marrow, but often remain in the skin. Normally, the body strongly control the population of lymphocytes, as it does with other cells. In a healthy immune system, new cells are created only to replace dying cells or depleted. With CTCL, malignant white blood cells produce abnormal and uncontrollable way.

The figure shows the rapid growth of the T cells from a patient with fungus fungoids

CLO itself has many subtypes: the most common of which are fungoids Fungoides and Sézary syndrome. fungoids Fungoides are cancer of the slow movement identified in the later stages by tumors in the shape of fungus on the skin. This cancer often remains in the skin and does not move to the organ system until its later stages. Conversely, Sézary syndrome is a cancer of much more aggressive leukemia type characterized by hypertrophy of the lymph nodes, a large number of malignant T cells in the blood, and the very visible effects on the skin. Although neither State is considered to be life-threatening, the effects can be very painful and very visible.

T lymphomas represent approximately 15% of all lymphomas not hodgkiniens, the United States (lymphomainfo.net). CTCL is up to 2-3% of cases of lymphoma non-Hodgins (Foundation Lymphoma Research 2008). Less frequent than B lymphomas, CLO can generally not be deadly, but there is also currently no treatment available. Same effective long-term treatment was rare. Over the past years, it was thought that the human lymphotrope virus-1 may be involved in the onset of lymphomas in T cells related a lot who have the virus in their systems never contract-related cancers, similar to carcinoma Merkel and Merkel cell associated polyomaviruses.

Most often, related T-cell cancers are diagnosed by biopsy of tumors or related skin formations. However, Clos can be difficult to detect immediately, because cells may appear to be indistinguishable from those who are healthy. This requires blood tests, to determine the final results. In addition, the first symptoms are often very similar or identical to eczema and psoriasis. The resemblance to these conditions often prevents CTCL unnoticed for years, leading to complications with the treatment and the worsening of the condition of the patient. If you showed similar symptoms for longer periods, it would be wise to consult your doctor or a specialist about the tests of cutaneous T-cell lymphoma and other cancers of the skin.

The treatments available for range CLO of topical and pharmaceutical products to ultraviolet light, electron beam radiation therapy, surgery and chemotherapy. The course of treatment chosen is related to subtype of CLO contracted, as well as the stage of cancer. This difficult to treat the condition has been notoriously problematic with regard to effective treatments. It is for this reason that OncoSec has engaged in clinical trials using immunotherapy. If you or a be expensive contracted CTCL, this trial will be soon opened to the recruitment of participants. For more information, please see this document.

If you want to learn more about the cutaneous lymphoma cells T or OncoSec, please visit our web site. You can also contact us on Facebook and Twitter.